摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

10-benzyl-8-methyl-1,10-diazabicyclo[7.4.0]tridecane

中文名称
——
中文别名
——
英文名称
10-benzyl-8-methyl-1,10-diazabicyclo[7.4.0]tridecane
英文别名
1-benzyl-12-methyl-3,4,6,7,8,9,10,11,12,12a-decahydro-2H-pyrimido[1,2-a]azonine
10-benzyl-8-methyl-1,10-diazabicyclo[7.4.0]tridecane化学式
CAS
——
化学式
C19H30N2
mdl
——
分子量
286.461
InChiKey
BEZORAZYWWXCIP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.8
  • 重原子数:
    21
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.68
  • 拓扑面积:
    6.5
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为产物:
    描述:
    N-(oct-7-enyl)propane-1,3-diamine 在 dirhodium tetraacetate 、 三苯基膦 sodium tetrahydroborate 、 氢气 作用下, 以 甲醇 为溶剂, 80.0 ℃ 、2.76 MPa 条件下, 反应 25.0h, 生成 10-benzyl-8-methyl-1,10-diazabicyclo[7.4.0]tridecane
    参考文献:
    名称:
    A Hydroformylation Route to Diazabicycloalkanes and Oxazabicycloalkanes Containing Medium and Large Rings
    摘要:
    含有中环和大环的重氮双环烷烃和恶唑双环烷烃 可通过铑催化反应制备 N-烯基丙烷-1,3-二胺和 2-(烯氨基)乙醇与 H2/CO 发生铑催化反应,可以制备含有中环和大环的 收率极高,无需高度稀释。这些化合物的选择性开环 可生成大型杂环。
    DOI:
    10.1071/ch99097
点击查看最新优质反应信息

文献信息

  • High yields of diazabicycloalkanes and oxazabicycloalkanes containing medium and large rings from rhodium-catalysed hydroformylation reactions without the need for high dilution conditions
    作者:David J. Bergmann、Eva M. Campi、W. Roy Jackson、Antonio F. Patti
    DOI:10.1039/a903638e
    日期:——
    Rhodium-catalysed reactions of N-alkenyl-1,3-diaminopropanes and N-alkenylaminoethanols give diazabicycloalkanes and oxazabicycloalkanes containing medium or large rings in excellent yields.
    铑催化的N-烯基-1,3-二胺丙烷和N-烯基氨基乙醇反应能高产率地生成含有中环或大环的二氮双环烷烃和氧氮双环烷烃。
  • Photoactivable nitrogen bases
    申请人:——
    公开号:US20040242867A1
    公开(公告)日:2004-12-02
    Compounds of the formula I R7″N—R6 RS—C,N—R4 H C, R′/I R, 3 R 2 (I) in which R, is an aromatic or heteroaromatic radical which is capable of absorbing light in the wave-length range from 200 nm to 650 nm and which is unsubstituted or substituted one or more times by C,—C,8alkyl, C2-C,ealkenyl, C2-C,8alkynyl, C,—C,ehaloalkyl, NO2, NR,OR, CN, OR,2, SR,2, C(O)R,3, C(O)OR,4, halogen or a radical of the formula II R˜—N′ R6 1 R5-C,N.R4 H I C—R3 I R2 (E) and which on absorption brings about a photoelimination which leads to the generation of an amidine group, R2 and R3 independently of one another are hydrogen, C,—C,ealkyl or phenyl which is unsubstituted or is substituted one or more times by C,—C,8alkyl, CN, OR,2, SR,2, halogen or C,—C,ehaloalkyl; R5 is C,—C,ealkyl or NR8R9; R4, R6, R, R8, R9, R,o and R inde-pendently of one another are hydrogen or C,—C,8alkyl; or R4 and R6 together form a C2-C,2alkylene bridge which is unsubstituted or is substituted by one or more C1-C4alkyl radicals; or R5 and R, independently of R4 and R6, together form a C2-C,2alkylene bridge which is unsubstituted or is substituted by one or more C1-C4alkyl radicals; or, if R5 is a radi-cal NR8R9, R, and R9 together form a C2-C,2alkylene bridge which is unsubstituted or is substituted by one or more C1-C4alkyl radicals; and R,2, R,3 and R,4 independently of one another are hydrogen or C,—C,ealkyl; are suitable as photoinitiators for compounds which react under base catalysis. 1
    公式I中的化合物,其中R,是一种芳香或杂芳基团,能够在200nm至650nm的波长范围内吸收光,并且未被取代或被C,-C,8烷基,C2-C,e烯基,C2-C,8炔基,C,-C,卤代烷基,NO2,NR,OR,CN,OR,2,SR,2,C(O)R,3,C(O)OR,4,卤素或公式II R' -N' R6 1 R5-C,N.R4 H I C-R3 I R2(E)取代一次或多次,吸收后引起光消除,导致产生酰胺基团,其中R2和R3独立地是氢,C,-C,e烷基或苯基,未被取代或被C,-C,8烷基,CN,OR,2,SR,2,卤素或C,-C,卤代烷基取代;R5是C,-C,e烷基或NR8R9;R4,R6,R,R8,R9,R,o和R独立地是氢或C,-C,8烷基;或R4和R6共同形成一个未被取代或被一个或多个C1-C4烷基基团取代的C2-C,2烷基桥;或R5和R,独立于R4和R6,共同形成一个未被取代或被一个或多个C1-C4烷基基团取代的C2-C,2烷基桥;或者,如果R5是一个基团NR8R9,R,和R9共同形成一个未被取代或被一个或多个C1-C4烷基基团取代的C2-C,2烷基桥;而R,2,R,3和R,4独立地是氢或C,-C,e烷基;适用于在碱催化下反应的化合物的光引发剂。
  • Letter with continuation application
    申请人:Baudin Gisele
    公开号:US20090076200A1
    公开(公告)日:2009-03-19
    Base-polymerizable or base-crosslinkable compositions comprising select bicyclic amines with benzylic substitution undergo photochemically induced, base-catalysed reactions upon photochemical conversion of the benzylically substituted amine to an amidine derivative.
    含有选择的苯基取代双环胺的基团可聚合或交联的组合物,在苯基取代胺光化学转化为酰胺衍生物时,经光化学诱导和碱催化反应。
  • CURABLE-ON-DEMAND COMPOSITION COMPRISING DUAL REACTIVE SILANE FUNCTIONALITY
    申请人:Yang Yu
    公开号:US20130178553A1
    公开(公告)日:2013-07-11
    A curable composition comprises (a) at least one inorganic or organic compound comprising reactive silane functionality comprising at least one hydrosilyl moiety; (b) at least one inorganic or organic compound comprising reactive silane functionality comprising at least one hydroxysilyl moiety, the hydroxysilyl moiety optionally being generated in situ by hydrolysis of at least one hydrosilyl moiety; and (c) at least one photoactivatable composition that, upon exposure to radiation, generates at least one base selected from amidines, guanidines, phosphazenes, proazaphosphatranes, and combinations thereof; with the proviso that, when component (a) is an organic polymer, then component (b) is different from component (a) and is not generated in situ by hydrolysis of component (a).
    一种可治愈的组合物包括:(a)至少一种含有反应性硅烷官能团的无机或有机化合物,其中硅烷官能团包括至少一个氢硅烷基;(b)至少一种含有反应性硅烷官能团的无机或有机化合物,其中硅烷官能团包括至少一个羟基硅烷基,羟基硅烷基可以通过至少一个氢硅烷基的水解而在原位生成;以及(c)至少一种光活性组合物,当暴露于辐射下时,生成至少一种从氨基甲酸酰胺、鸟嘌呤、磷氮烷、丙氨酸磷酸酯和其组合物中选择的碱,前提是当组分(a)是有机聚合物时,组分(b)与组分(a)不同,并且不是通过组分(a)的水解在原位生成的。
  • CURABLE-ON-DEMAND POLYSILOXANE COATING COMPOSITION
    申请人:Yang Yu
    公开号:US20130101841A1
    公开(公告)日:2013-04-25
    A curable composition comprises (a) at least one polydiorganosiloxane, fluorinated polydiorganosiloxane, or combination thereof comprising reactive silane functionality comprising at least two hydroxysilyl moieties; (b) at least one polydiorganosiloxane, fluorinated polydiorganosiloxane, or combination thereof comprising reactive silane functionality comprising at least two hydrosilyl moieties; and (c) at least one photoactivatable composition that, upon exposure to radiation, generates at least one base selected from amidines, guanidines, phosphazenes, proazaphosphatranes, and combinations thereof; wherein at least one of the components (a) and (b) has an average reactive silane functionality of at least three.
    可治疗组合物包括:(a)至少一种聚二甲基硅氧烷、氟代聚二甲基硅氧烷或二者的组合物,其包含具有至少两个羟基硅基的反应性硅烷官能团;(b)至少一种聚二甲基硅氧烷、氟代聚二甲基硅氧烷或二者的组合物,其包含具有至少两个氢硅基的反应性硅烷官能团;以及(c)至少一种光致活性组分,当暴露于辐射下时,会产生从氨基化合物、胍化合物、磷氮化合物、脲基磷杂环丙烷和它们的组合物中选择的至少一种碱;其中,组分(a)和/或(b)中至少有一种的平均反应性硅烷官能团为至少三个。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐